Actinium Pharmaceuticals, Inc. (ATNM)

Retained Earnings

-$387.33M

Quarterly · Period ending: · USD

ATNM logo

ATNM Retained Earnings

Latest reported-$409.71M
ATNM FY Retained Earnings (-$193.84K → -$409.71M)
High-resolution chart · PNG

ATNM retained earnings history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. Retained Earnings — Annual fiscal periods (USD)
Period endingRetained Earnings (USD)
-409,713,000
-375,826,000
-337,583,000
-288,765,000
-255,748,000
-230,974,000
-208,757,561
-186,857,238
-163,153,037
-136,551,802
-112,230,078
-91,204,764
-66,517,255
-55,743,463
-259,764
-270,053
-271,727
-249,396
-208,639
-193,839
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.